webinar register page

Webinar banner
Spray Drying: A QbD approach to improve bioavailability
Spray drying is a continuous, reproducible, cost-effective, and scalable process to produce dry powders from a liquid solution or suspension by rapidly drying with a hot gas. The main reason for its growth in the pharmaceutical industry in the recent years has been the formulation of amorphous solid dispersions for oral drugs to increase the solubility and bioavailability of poorly soluble compounds. Apart from this, Spray Drying is a well-suited technology to produce, not only solid dispersions, but it is also widely used in the field of microencapsulation, nanotechnology, drug combination, proteins, probiotics, inhalation powders, vaccines and, even, feasible organisms.

The use of the Quality by Design (QbD) methodology allows the product and process understanding and facilitates the development of the spray drying process in an efficient and cost-effective way. This approach is employed to identify, from early stages, the risks related to the formulation and manufacturing process that can potentially impact product quality and, consequently, helps to guide studies to mitigate such risks. Adopting a QbD methodology from the initial development for first clinical trials is highly recommended for a more robust process for the remaining stages of the clinical program.

The implementation of this systematic approach based on sound science and quality risk management principles, through tools like Design of Experiments (DoE), allows a deeper knowledge of the product and manufacturing processes, minimizing risks and saving time and resources.

In this webinar, we will provide useful guidelines and tips for a QbD approach in Spray Drying processes, highlighting the key variables to consider and explaining its application with a case study.

Oct 28, 2021 04:00 PM in Madrid

Webinar logo
* Required information
By clicking on the registration button, you accept that the data provided on this form will be procesed, stored and used in accordance with the terms set out in our Data Protection Policy


Javier Gurrea
Pharmaceutical Development and Spray Drying Manufacturing Scientist @Idifarma
Javier Gurrea has 5 years of experience in Pharmaceutical Development and GMP Manufacturing. His work is focused on the development and manufacturing of drug products with Spray Drying technology. He has been involved in numerous projects based especially on amorphous solid dispersions, as well as working on other applications of this technology including micro and nanoparticles. Javier has a double degree in Pharmacy and Nutrition from the University of Navarra (Spain).
Stefano Console
Senior Advisor @Oriento
Stefano Console has more than 27 years of experience in the pharmaceutical and fine chemical business. The broad experience gained with different CDMOs coupled with an unceasing scientific curiosity for new technologies led Stefano to hold strategic roles managing a large number of successful projects for big as well as small Pharma partners across EU, USA and Japan. A vibrant passion for business development, organizational innovation and start-up initiatives, together with a relevant expertise in pharmaceutical particle engineering technologies (especially micronization and spray drying related technologies) and respiratory products complete the profile. Currently Stefano is Senior Advisor and Founder at Oriento SA, Member of the Advisory Board at eu.reca (European Respiratory Cluster of Antwerp) and Scientific Advisor at Idifarma. Stefano received his five-year degree in Chemistry from the University of Milano, Italy.